Weighted Gene Co-expression Network Analysis of Gene Modules for Lung Adenocarcinoma
暂无分享,去创建一个
Yuanyuan Zhai | Yue Jiang | Qianzhong Li | Ying-Li Chen | Ying-Li Chen | Qianzhong Li | Yue Jiang | Yuanyuan Zhai
[1] Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and The European Respiratory Society. , 1997, American journal of respiratory and critical care medicine.
[2] H. Takayama,et al. A Novel Association of Fc Receptor γ-Chain with Glycoprotein VI and Their Co-expression as a Collagen Receptor in Human Platelets* , 1997, The Journal of Biological Chemistry.
[3] Y. Iwakura,et al. IL-1 is required for tumor invasiveness and angiogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[4] Michael F Beers,et al. Surfactant protein C biosynthesis and its emerging role in conformational lung disease. , 2005, Annual review of physiology.
[5] Yoichiro Iwakura,et al. Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. , 2007, Cancer research.
[6] Luigi Naldini,et al. FcRgamma activation regulates inflammation-associated squamous carcinogenesis. , 2010, Cancer cell.
[7] Geoff Kelly,et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase , 2011, Nature.
[8] Thomas Hollis,et al. Aicardi-Goutières Syndrome Gene and HIV-1 Restriction Factor SAMHD1 Is a dGTP-regulated Deoxynucleotide Triphosphohydrolase*♦ , 2011, The Journal of Biological Chemistry.
[9] Jie Chen,et al. Long Noncoding RNA Expression Profiles of Lung Adenocarcinoma Ascertained by Microarray Analysis , 2014, PloS one.
[10] Yun Wu,et al. SAMHD1 is down regulated in lung cancer by methylation and inhibits tumor cell proliferation. , 2014, Biochemical and biophysical research communications.
[11] A. Jemal,et al. Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[12] Nicholas Borcherding,et al. Obesity-associated NLRC4 inflammasome activation drives breast cancer progression , 2016, Nature Communications.
[13] A. Jemal,et al. Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.
[14] Fan Tong,et al. Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion, c-Met overexpression, and HER-2 amplification with inherent resistance to crizotinib, chemotherapy, and radiotherapy , 2016, Journal of Hematology & Oncology.
[15] R. Boldrini,et al. Surfactant Protein C-associated interstitial lung disease; three different phenotypes of the same SFTPC mutation , 2016, Italian Journal of Pediatrics.